Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
The EXPO news page on Stock Titan aggregates recent press releases and market-moving updates related to Exponent, Inc., a science and engineering consulting firm listed on Nasdaq. Exponent reports regularly on its financial results, business trends across its engineering and other scientific segment and its environmental and health segment, and developments in the industries it serves. These updates often include commentary on dispute-related engagements, proactive risk management projects, and regulatory consulting work.
Investors following EXPO news can review quarterly earnings releases that discuss revenues before reimbursements, operating income, net income, and non-GAAP measures such as EBITDA and EBITDAS. Management commentary provides context on demand in sectors such as construction, automotive, medical devices, chemicals, transportation, utilities, life sciences, consumer electronics, and consumer products. Releases also describe how Exponent’s multidisciplinary teams address issues like failure analysis, asset integrity, digital health, artificial intelligence usability, and distributed energy systems.
In addition to earnings, Exponent’s news flow includes announcements about regular quarterly cash dividends and share repurchase authorizations. The company has reported dividend declarations for multiple quarters and increases to its stock repurchase program, offering insight into its capital allocation approach. Other items covered in EXPO news include scheduling and access details for quarterly conference calls and webcasts where executives discuss business performance and outlook.
By monitoring the EXPO news page, readers can track how Exponent’s two operating segments perform over time, how demand is evolving across the industries it serves, and how the company uses dividends and repurchases alongside investment in talent and capabilities. This page is a convenient way to review Exponent’s official communications and financial updates in one place.
Exponent (Nasdaq: EXPO) announced a quarterly cash dividend increase from $0.30 to $0.31 per share for Q1 2026. The dividend will be paid on March 20, 2026 to holders of record as of March 6, 2026. Exponent intends to continue regular quarterly dividends each March, June, September, and December, with future declarations subject to Board approval.
Exponent (Nasdaq: EXPO) reported Q4 and fiscal 2025 results: Q4 revenue $147.4M (+7.8% vs. prior-year quarter) and FY revenue $582.0M (+4.2% vs. prior year). Q4 net income was $24.8M ($0.49 diluted EPS); FY net income was $106.0M ($2.07 diluted EPS). EBITDA for FY 2025 was $148.1M (27.6% of revenues before reimbursements). The board raised the quarterly cash dividend to $0.31 payable March 20, 2026, and the company repurchased $97.8M of common stock during the year.
Management expects high-single-digit revenue growth for Q1 and full-year 2026 and FY EBITDA margin around 27.6%–28.1% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) declared a quarterly cash dividend of $0.30 per share, payable on December 19, 2025 to stockholders of record as of December 5, 2025. The company expects to continue quarterly dividends in March, June, September, and December, subject to Board approval.
Separately, the Board increased the share repurchase authorization by $100 million, adding to the $21.6 million available for repurchase as of October 3, 2025. Management cited strong cash flow and balance sheet strength as the rationale for these capital-allocation actions.
Exponent (Nasdaq: EXPO) reported third-quarter fiscal 2025 results for the period ended October 3, 2025. Q3 revenues rose 8% to $147.1M and revenues before reimbursements rose 10% to $137.1M. Net income was $28.0M, or $0.55 diluted EPS. EBITDA was $38.8M (28.3% of revenues before reimbursements). Year-to-date revenues rose 3% to $434.6M while net income decreased to $81.2M. The company paid $46.7M in dividends, repurchased $72.7M of stock, and ended the period with $207.4M cash. The Board approved a $100M increase to the buyback program and declared a $0.30 quarterly dividend.
Q4 and full-year 2025 guidance includes modest revenue growth and EBITDA margin ranges of 26.0%–27.0% (Q4) and 27.4%–27.65% (full year).
Exponent (Nasdaq: EXPO) will report Third Quarter fiscal 2025 results for the period ended October 3, 2025 after market close on Thursday, October 30, 2025. A conference call and webcast with CEO Dr. Catherine Corrigan and EVP/CFO Richard Schlenker will be held at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss business and financial results.
Investors can join live by dialing (844) 481-2781 or (412) 317-0672, or listen via a live and archived webcast at the company Investor Relations site. A telephonic replay is available through Thursday, November 6, 2025 at (877) 344-7529 or (412) 317-0088 with passcode 1587971#.
Exponent (NASDAQ: EXPO) has declared a quarterly cash dividend of $0.30 per share for Q3 2025. The dividend will be paid on September 19, 2025, to stockholders of record as of September 5, 2025.
The company maintains its regular quarterly dividend schedule in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholder returns and highlighted Exponent's strong market position in safety, health, and environmental services.
Exponent (NASDAQ: EXPO) reported its Q2 2025 financial results with total revenues of $142.0 million, up 1% year-over-year. The company's revenues before reimbursements remained relatively flat at $132.9 million. Net income decreased to $26.6 million ($0.52 per diluted share) from $29.2 million ($0.57 per diluted share) in Q2 2024.
The engineering segment, representing 85% of revenues, grew 1% driven by dispute-related services in construction, automotive, and medical device sectors. The environmental and health segment declined 4%. EBITDA margin decreased to 27.8% from 30.2% year-over-year.
The company maintained its full-year 2025 guidance, expecting low single-digit growth in revenues and EBITDA margin between 26.50% to 27.0%. Exponent also announced a quarterly dividend of $0.30 per share.
Exponent (NASDAQ:EXPO) has scheduled its Second Quarter Fiscal Year 2025 earnings conference call for July 31, 2025, at 4:30 p.m. ET. The company will release its financial results for the period ended July 4, 2025, after market close on the same day.
CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will host the call. Investors can access the live call via phone or through a webcast on the company's investor relations website. A replay will be available until August 7, 2025.
Exponent Inc. (NASDAQ: EXPO) has declared a quarterly cash dividend of $0.30 per share for Q2 2025. The dividend will be paid on June 20, 2025 to stockholders of record as of June 6, 2025. The company maintains a regular quarterly dividend schedule in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized that the dividend reflects their commitment to shareholder value, highlighting the company's diversified services portfolio as a strength in navigating market volatility while pursuing growth opportunities.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
